Pharmacie V. Pirotte SRL
0.4 FTEPharmacie V. Pirotte reported total assets of 209,269 € at the end of the 2025 financial year (annual accounts filed with the NBB on 12 Jun 2026), with 0.4 full-time equivalent.
The score of Pharmacie V. Pirotte shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmacie V. Pirotte's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 12 Jun 2026
- Year ended 31 Dec 2024filed on 11 Apr 2025
Pharmacie V. Pirotte's financial analysis
- Solvency7.9%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmacie V. Pirotte
Pharmacie V. Pirotte's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1002.973.367
- VAT number
- BE1002973367
- Peppol
- Registered · 0208:1002973367 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 04 Dec 2023
- Registered office
- 4102 Seraing
- Size
- Micro · 0.4 FTE
- Latest accounts
- 2025 · filed on 12 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharmacie V. Pirotte (SRL) has been based in Seraing since 2023, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 5,652 € and equity of 16,636 €; its revenue is not published. With 0.4 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 7.9%, below the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharmacie V. Pirotte
Companies in the same business, of comparable size and area, outside its group.
- Apotheek van Hemelrijk Retail sale of pharmaceutical products Puurs-Sint-Amands · balance sheet 208,504 €
- Apopark Retail sale of pharmaceutical products Leuven · balance sheet 210,821 €
- Amboplus Retail sale of pharmaceutical products Knokke-Heist · balance sheet 212,418 €
- Castoro Retail sale of pharmaceutical products Pajottegem · balance sheet 213,183 €
- Le Lumeçon Retail sale of pharmaceutical products Brussels · balance sheet 213,394 €
- MDB Pharma Retail sale of pharmaceutical products Ghent · balance sheet 214,811 €
- Pharmasolutions Retail sale of pharmaceutical products Linkebeek · balance sheet 215,436 €
- Phidelta Pharma Retail sale of pharmaceutical products Liège · balance sheet 216,336 €
Frequently asked questions about Pharmacie V. Pirotte
What is the revenue of Pharmacie V. Pirotte?
Pharmacie V. Pirotte files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmacie V. Pirotte?
In Belgium, the VAT number is the company number prefixed with BE: BE1002973367 for Pharmacie V. Pirotte, if the company is VAT-registered. Its company number (CBE) is 1002.973.367.
Where is the registered office of Pharmacie V. Pirotte?
According to the CBE register, the registered office of Pharmacie V. Pirotte is in 4102 Seraing.
What is the equity of Pharmacie V. Pirotte?
At the close of the 2025 financial year, the equity of Pharmacie V. Pirotte amounts to 16,636 €, a solvency of 7.9% of total assets.
How many people work at Pharmacie V. Pirotte?
0.4 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pharmacie V. Pirotte?
The register lists 1 active mandates at Pharmacie V. Pirotte. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmacie V. Pirotte
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →